INCOME STATEMENT
Gland Pharma Ltd.
BSE
Jun 06
1640.65
+10.55 (+ 0.65%)
Volume
2361
Prev. Close
1630.10
Open Price
1649.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 06
1642.00
+8.40 (+ 0.51%)
Volume
95999
Prev. Close
1633.60
Open Price
1644.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE068V01023
|
Market Cap. ( ₹ in Cr. )
|
27053.00
|
P/BV
|
3.08
|
Book Value ( ₹ )
|
533.39
|
|
BSE Code
|
543245
|
52 Week High/Low ( ₹ )
|
2221/1278
|
FV/ML
|
1/1
|
P/E(X)
|
38.73
|
|
NSE Code
|
GLANDEQ
|
Book Closure
|
14/08/2025
|
EPS ( ₹ )
|
42.40
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 4116.15 | 4144.44 | 3583.79 | 4384.15 | 3423.64 |
| Other Operating Revenues | 0.00 | 22.99 | 32.74 | 16.56 | 39.24 |
| Total Operating Revenues | 4116.15 | 4167.43 | 3616.53 | 4400.71 | 3462.88 |
| | | | | | |
| Other Income | 215.08 | 166.67 | 240.46 | 223.94 | 134.78 |
| Total Revenue | 4331.22 | 4334.09 | 3856.99 | 4624.65 | 3597.65 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1585.86 | 1826.94 | 1716.75 | 2046.86 | 1749.16 |
| Purchase Of Stock-In Trade | 14.49 | 23.14 | 15.59 | 25.67 | 16.20 |
| Operating And Direct Expenses | 0.00 | 0.00 | 124.84 | 95.05 | 74.59 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 130.25 | 87.43 | -46.92 | 36.69 | -273.49 |
| Employee Benefit Expenses | 439.02 | 409.95 | 399.70 | 338.57 | 311.36 |
| Finance Costs | 22.84 | 7.84 | 7.41 | 5.24 | 3.41 |
| Depreciation And Amortisation Expenses | 169.27 | 162.11 | 146.74 | 110.30 | 98.78 |
| Other Expenses | 503.91 | 411.20 | 388.01 | 347.23 | 282.79 |
| Total Expenses | 2865.64 | 2928.60 | 2752.13 | 3005.61 | 2262.80 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1465.59 | 1405.50 | 1104.86 | 1619.04 | 1334.85 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | -56.46 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 1465.59 | 1405.50 | 1048.40 | 1619.04 | 1334.85 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 375.83 | 341.02 | 276.19 | 395.88 | 339.45 |
| Deferred Tax | 0.00 | 24.68 | -2.80 | 14.01 | 0.12 |
| Tax For Earlier Years | 0.00 | -3.53 | -0.82 | -3.00 | -1.72 |
| Total Tax Expenses | 375.83 | 362.17 | 272.58 | 406.89 | 337.85 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1089.75 | 1043.33 | 775.83 | 1212.16 | 997.01 |
| | | | | | |
| Profit/Loss From Continuing Operations | 1089.75 | 1043.33 | 775.83 | 1212.16 | 997.01 |
| | | | | | |
| Profit/Loss For The Period | 1089.75 | 1043.33 | 775.83 | 1212.16 | 997.01 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 66.15 | 63.35 | 47.12 | 73.84 | 63.07 |
| Diluted EPS (Rs.) | 66.15 | 63.35 | 47.11 | 73.67 | 62.99 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Dividend Rate (%) | 1800.00 | 0.00 | 0.00 | 0.00 | 0.00 |